S365: A Multicenter Longitudinal Cohort of Sleep Health
S365
Establishment of a Multicenter Longitudinal Cohort of Sleep With Long-term Monitoring at Home
1 other identifier
observational
5,000
1 country
1
Brief Summary
The goal of this observational study is to explore the long-term health outcomes of sleep disorders in adults aged 18 and older, as well as to identify associated biomarkers and risk factors. The main questions it aims to answer are:
- What are the long-term health risks associated with sleep disorders, such as cognitive decline, cardiovascular diseases, or metabolic conditions?
- Are there specific biomarkers or patterns that can predict the onset or progression of sleep disorders? Participants diagnosed with sleep disorders (e.g., insomnia, sleep apnea) or identified as healthy controls will undergo home-based sleep monitoring and complete clinical assessments at baseline and during follow-ups over a 3-year period. Biological samples, including blood and stool, will also be collected to analyze potential biomarkers. Data will be used to develop predictive models for sleep disorder risk and outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2024
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
December 29, 2024
CompletedFirst Posted
Study publicly available on registry
January 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2031
January 6, 2025
December 1, 2024
6.4 years
December 29, 2024
December 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of Sleep Disorders and Related Diseases
* Measure the occurrence of sleep disorders and related diseases, including cognitive decline, cardiovascular diseases, and metabolic conditions, over the follow-up period. * Data will be collected through clinical evaluations, sleep monitoring (e.g., polysomnography, wearable devices), and laboratory analyses (e.g., blood biomarkers). * Key metrics include the development or progression of these conditions, assessed through standardized diagnostic criteria.
36 months (Baseline and follow-ups at 12, 24, and 36 months)
Interventions
Non-contact mat monitoring sleep data through pulse wave detection
Eligibility Criteria
The study population will include adults aged 18 years and older, recruited from two primary sources: clinical sleep centers and online advertisements. Participants will be divided into two groups: those diagnosed with sleep disorders, including insomnia, sleep apnea, and parasomnia, and healthy controls with no clinical symptoms. Individuals with sleep disorders will be identified through polysomnography or equivalent diagnostic methods, ensuring accurate categorization. Recruitment will target a diverse population to reflect a broad range of demographic and lifestyle factors, such as age, gender, and socio-economic background. The healthy control group will include individuals diagnosed as free from sleep-related conditions during clinical evaluations or through self-reported health statuses verified by researchers. Exclusion criteria include individuals with severe mental illnesses (e.g., bipolar disorder, schizophrenia), infectious diseases (e.g., tuberculosis, HIV/AIDS), pregnan
You may qualify if:
- Willing to voluntarily participate in the study and provide signed informed consent.
- Gender is not restricted, and baseline age is 18 years or older.
- Experiencing sleep disorders and capable of complying with the study procedures and tests.
You may not qualify if:
- Diagnosed with severe mental health conditions, such as bipolar disorder, schizophrenia, or claustrophobia.
- Suffering from infectious diseases, including tuberculosis, HIV/AIDS, or syphilis.
- Pregnant women.
- Experiencing acute inflammatory responses at the time of enrollment.
- Long-term use of corticosteroids or undergoing hormone replacement therapy.
- Determined by the researcher to be unsuitable for participation for any reason.
- Patients with specific diseases (e.g., cardiovascular conditions) may be excluded if the study focuses on related comorbidities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Medical Technology, Peking University Health Science Center
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 29, 2024
First Posted
January 6, 2025
Study Start
August 1, 2024
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2031
Last Updated
January 6, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
We plan to share the individual participant data (IPD) that are necessary for presenting the results included in publications. This will include de-identified data related to key outcomes, such as demographic information, clinical assessments, and sleep monitoring results. Additional data beyond what is included in the publications may be available upon reasonable request. Researchers interested in accessing these data should contact the project lead, who will evaluate requests on a case-by-case basis to ensure compliance with ethical and legal guidelines.